MyLymphomaTeam

Does receiving immunoglobulin (antibody) treatment after R-CHOP, radiotherapy, and Rituximab indicate a relapse of lymphoma?

Receiving immunoglobulin therapy does not necessarily mean a relapse has occurred. R-CHOP and Rituximab can significantly weaken the immune system, particularly by reducing the body's ability to Show Full Answer

Does receiving immunoglobulin (antibody) treatment after R-CHOP, radiotherapy, and Rituximab indicate a relapse of lymphoma?

Receiving immunoglobulin therapy does not necessarily mean a relapse has occurred. R-CHOP and Rituximab can significantly weaken the immune system, particularly by reducing the body's ability to produce its own antibodies. Immunoglobulin treatment is often given to help support the immune system during or after treatment — not specifically as a sign that lymphoma has returned. Signs that might suggest a relapse are different and can include:

- New or returning swollen lymph nodes
- Unexplained fevers or night sweats
- Unusual fatigue or weight loss
- Results from scans (PET or CT) showing lymphoma activity

The best person to clarify why immunoglobulin therapy was recommended in your specific case is your medical team. They can confirm whether it's purely immune support or related to any changes in your condition. Don't hesitate to ask them directly — it's a completely reasonable question!

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Early vs. Advanced DLBCL: How Are They Treated Differently?

5 Facts About R-CHOP Chemo for DLBCL and What To Expect